Navigation Links
Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results
Date:11/5/2012

due to increased product sales.  

As of September 30, 2012, Cadence reported cash, cash equivalents and short-term investments of $74.5 million and net accounts receivable of $6.8 million.

GuidanceAs of November 5, 2012, Cadence expects that net product revenue from sales of OFIRMEV for the three months ending December 31, 2012, will range from approximately $15.9 million to $16.4 million.

Conference Call and Webcast on November 5, 2012 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) Cadence management will host a conference call on November 5, 2012, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) and interested investors may participate in the conference call by dialing (877) 303-9145 (domestic) or (760) 536-5203 (international). To access the webcast, please visit the company's website at www.cadencepharm.com and go to the Investors page. A replay of the webcast will be available approximately two hours after the call and remain available on the company's website until the next quarterly financial results call. Cadence uses the Investors portion of its website as one means of disclosing material non-public information, and investors are encouraged to monitor Cadence's website in addition to following the company's press releases, SEC filings and public conference calls and webcasts.

About OFIRMEV® (Acetaminophen) InjectionOFIRMEV (acetaminophen) injection (1000 mg / 100 mL, 10 mg / mL; for intravenous use only), Cadence Pharmaceuticals' proprietary intravenous formulation of acetaminophen, is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever. The FDA approval of OFIRMEV was based on data from clinical trials in approximately 1,020 adult and 355 pediatric patients. These trials included two studies evaluating the safety and effectiveness of OFIRMEV in the trea
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
2. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2012 Financial Results On August 2, 2012
3. Cadence Pharmaceuticals To Present At The Wedbush PACGROW Life Sciences Management Access Conference In New York City On August 14, 2012
4. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2012 In Boston On September 5, 2012
5. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2012 Financial Results On November 5, 2012
6. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013  Regulatory and marketplace changes ... many organizations, priority list. Forward-thinking ... understand a strong Medical Affairs function ... development, market education , and regulatory compliance. ... vital bridge between an organization and one of ...
(Date:5/24/2013)... LAKES, N.J. , May 24, 2013  BD (Becton, ... global medical technology company, announced today that it will present ... Conference on Thursday, May 30, 2013, at 10:40 a.m. (ET). ... be accessed from the BD corporate website at www.bd.com/investors ... 6, 2013.    About BD BD ...
(Date:5/24/2013)... BEVERLY HILLS, Calif. , May 24, 2013 /PRNewswire-iReach/ ... the state,s leading non-profit substance abuse services organization, is ... at the Beverly Hills Hotel on June 6, 2013.  ... event to raise funds for the adolescent residential treatment ... as well as honor individuals whose accomplishments have positive ...
Breaking Medicine Technology:Building Medical Affairs Capabilities to Ensure Organizational Success across Key Operational Areas 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 3
... BioTrends Research Group, Inc. released two syndicated ... Nephrology Q310 and TreatmentTrends®: Renal Dietitians 2010 ). ... with 200 nephrologists and 205 renal dietitians and ... behavior with a focus on renal anemia and ...
... Bioprobes today announced that the United States Patents ... covering novel blood protein biomarkers related to cardiovascular ... of patent applications that cover specific human protein ... "The biomarkers were discovered using Intrinsic Bioprobes, unique ...
Cached Medicine Technology:The Renal Anemia Market Shows Signs of Stabilization but Changes are Occurring in the Bone and Mineral Metabolism Market 2The Renal Anemia Market Shows Signs of Stabilization but Changes are Occurring in the Bone and Mineral Metabolism Market 3Intrinsic Bioprobes Announces Issuance of US Patent for Novel Biomarkers and Assays for Myocardial Infarction 2
(Date:5/25/2013)... Springs, FL (PRWEB) May 25, 2013 ... Dallas-Ft. Worth, Texas. It is the fifth largest media market ... Dallas is the number one visitor destination in Texas and ... cultural gateway to the American West as it is home ... activities everyone will enjoy from sports to the arts. Residents ...
(Date:5/25/2013)... May 25 (HealthDay News) -- Many viruses and parasites ... and leptospirosis -- a bacteria-borne illness than can result ... at dog parks, according to a veterinarian. ... and even the air, said Dr. Susan Nelson, a ... Center. "Many of these serious diseases can be fatal, ...
(Date:5/25/2013)... 25, 2013 Radius Engineering International ... company in the US and has been building ... over 35 years. M.E. and President, Walton McCarthy, ... NBC Weapon Fundamentals and Shelter Engineering Standards, Sixth ... on shelter engineering. McCarthy is considered the leading ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Absolute Surgical Specialists, ... many of the NALA’s businesses throughout the country participating in ... to participate in the nationwide event as he understands what ... Colonel in the Army. He said, “I wanted to give ... I serve, but I live here too.” , Shop Local ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 The ... ranging from irritable bowel syndrome (IBS) to bloating, ... among the most long-lasting, embarrassing, frustrating and difficult ... foods for digestive health have provided a ... are many factors contributing to digestive health issues, ...
Breaking Medicine News(10 mins):Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2Health News:Hidden Dangers Dog Dog Parks 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2
... acts in New York and Washington DC, air transportation ... several days, which severely affected the production and distribution ... due to their specific nature. These products are either ... component, and are used in diagnosis or therapy based ...
... your diet can affect your vision, according to a new ... of the eye causing fuzziness, shadows and severe visual impairment. ... diet has been implicated in its development. // ... a study of 349 individuals aged 55 to 80 with ...
... about the dramatic rise in overseas drug testing and ... experimental medicines and Americans who buy products based on ... outside the United States who voluntarily report their experiments ... dwarfing the agency's ability to inspect the test sites. ...
... by high rates of relapse, even after prolonged drug abstinence. ... Medical Center in the Netherlands and the intramural laboratories of ... process in the brain that may lead to a new ... // , In studies using rats, the ...
... Newborns are more likelier to develop a serious ... antibiotic erythromycin, say US scientists., ,A research team ... to pyloric stenosis, a condition that affects about 1 ... cause of abdominal surgery in infants. ,Using ...
... of drug-resistant E. coli has emerged as a possible ... a normal inhabitant of the digestive tract that can ... E. coli from bad food is a frequent cause ... were thought until now to result mostly from inadvertent ...
Cached Medicine News: